KKR launches Allyntra, a precision-engineered medtech platform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- Wells Fargo raises oil price targets citing ongoing supply risks
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries
July 9, 2026 6:59 AM EDTRobbie Atkinson appointed as CEO and Brian Highley appointed as Chairman
NEW YORK--(BUSINESS WIRE)-- KKR today announced the launch of Allyntra (Allyntra or the Company), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKRs existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntras growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial... More
